The preliminary results of the survey objectify the possibility that by using ALAnerv® to obtain a significant improvement of the neuromotor and sensitive/ functional outcomes and also to decrease the levels of fibrinogenemia, plasma leucocytes number and neutrophils percentage, but with no statistical significance for the ESR dynamics.